Saturday 17 October 2026 Export ANIP’s income statement to Excel — free account

ANI Pharmaceuticals, Inc.

ANIP Healthcare Drug Manufacturers Specialty & Generic

ANI Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $883.4 million, up 43.8% from fiscal 2024. In the quarter to June 2026, revenue grew 25.9%, EPS grew 194.6%, free cash flow fell 22.2% and total debt fell 1.78%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

72.08 0.20 −0.28%

Follow ANIP

Alert me

Market cap: $1.7B
P/E: 14.9×
Fwd P/E: 14.5×
Dividend yield: —
F-score: 7/9
Altman Z: 2.30
Beneish M: −2.62
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	20.88%	18.63%	16.34%	8.56%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	7	8	7	7
ROA Full definition →	7.61%	6.73%	5.66%	2.89%
ROIC Full definition →	11.30%	9.10%	8.05%	5.26%
Return on Tangible Assets Full definition →	17.56%	15.90%	14.36%	7.94%
Average Days of Receivables Full definition →	102.40	100.93	116.14	111.51
Free Cash Flow per Share Full definition →	7.92	8.74	7.53	6.74
Free Cash Flow Full definition →	167.52	182.81	150.90	135.32
Capital Expenditures Full definition →	(21.94)	(25.80)	(34.32)	(35.40)
Other line items
Cash ROIC Full definition →	10.58%	12.17%	10.39%	9.68%
Accounts Receivable Turnover Full definition →	3.91	3.88	3.51	3.68
Accounts Payable Turnover Full definition →	6.03	5.90	6.31	4.92
Inventory Turnover Full definition →	2.75	2.58	2.44	2.18
Average Days of Payables Full definition →	69.56	70.30	66.93	79.28
Days of Inventory on Hand Full definition →	134.87	144.71	153.00	166.39
Tax Rate Full definition →	(0.24)	(0.21)	(0.18)	(0.20)
Research and Development Expense of Revenue Full definition →	5.10%	5.60%	5.85%	6.78%
Selling, General and Administrative Expense of Revenue Full definition →	33.19%	34.09%	35.97%	36.85%
Share Based Compensation of Revenue Full definition →	4.20%	4.25%	4.29%	4.26%
Interest Coverage Full definition →	9.09	6.75	5.54	3.32
Operating CF/Net income Full definition →	1.75	2.28	2.40	4.38
Depreciation/Fixed assets Full definition →	1.17	1.33	1.46	1.60
Capex/Depreciation Full definition →	(0.26)	(0.29)	(0.38)	(0.35)
Revenue per Share Full definition →	46.24	44.17	44.05	41.19
Operating CF per Share Full definition →	8.95	9.97	9.24	8.50
Capex per Share Full definition →	(1.04)	(1.23)	(1.71)	(1.76)
Capex to Sales Full definition →	0.02	0.03	0.04	0.04

Fold the line items

Columns are period end dates

Stockrow Weekly